Cargando…
Liposomal bupivacaine administration is not superior to traditional periarticular injection for postoperative pain management following total knee arthroplasty: a meta-analysis of randomized controlled trials
BACKGROUND: Liposomal bupivacaine (LB) is a relatively new formulation that slowly releases bupivacaine to extend its efficacy for 72–96 h. It is inconclusive whether LB offers better efficacy than traditional periarticular injection (TPAI) following total knee arthroplasty (TKA). METHODS: Relevant...
Autores principales: | Chen, Jian-Jiun, Wu, Yun-Che, Wang, Jun-Sing, Lee, Cheng-Hung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018851/ https://www.ncbi.nlm.nih.gov/pubmed/36922892 http://dx.doi.org/10.1186/s13018-023-03699-4 |
Ejemplares similares
-
Periarticular injection of liposomal bupivacaine in total knee arthroplasty
por: Webb, Bradley T., et al.
Publicado: (2015) -
Improving total knee arthroplasty perioperative pain management using a periarticular injection with bupivacaine liposomal suspension
por: Snyder, Mark A., et al.
Publicado: (2016) -
Adductor Canal Block vs Liposomal Bupivacaine Periarticular Injection in Total Knee Arthroplasty: A Randomized Controlled Trial
por: Than, Justin, et al.
Publicado: (2021) -
Is periarticular injection superior to intraarticular injection to reduce postoperative pain following total knee arthroplasty?
por: Atik, O. Şahap, et al.
Publicado: (2022) -
Are reinfusion drains safe to use with periarticular liposomal bupivacaine? An analysis of systemic bupivacaine toxicity
por: Angerame, Marc R., et al.
Publicado: (2017)